Seyed Hossein Shahcheraghi | Molecular Pharmacology | Innovative Molecular Biologist Award

Published on by Molecular Biologist

Innovative Molecular Biologist Award

Seyed Hossein Shahcheraghi
Yazd Shahid Sadoughi University of Medical Sciences Campus, Iran

Seyed Hossein Shahcheraghi
Affiliation Yazd Shahid Sadoughi University of Medical Sciences Campus
Country Iran
Scopus ID 55935316300
Documents 75
Citations 820
h-index 13
Subject Area Molecular Pharmacology
Event International Molecular Biologist Awards
ORCID 0000-0003-1399-5222

Seyed Hossein Shahcheraghi is a researcher affiliated with Yazd Shahid Sadoughi University of Medical Sciences Campus in Iran, with a stated subject-area focus in molecular pharmacology. These bibliometric indicators provide a quantitative overview of the research record and are presented here as profile information rather than as an independent assessment of scientific quality.[1] [2]

Abstract

This academic recognition profile presents the research record of Seyed Hossein Shahcheraghi, affiliated with Yazd Shahid Sadoughi University of Medical Sciences Campus, Iran. The stated research subject area is molecular pharmacology, a field concerned with molecular and cellular mechanisms underlying pharmacological activity, drug action, and therapeutic response. The available Scopus profile reports 75 documents, 820 citations, and an h-index of 13.[1] The profile is additionally associated with ORCID identifier 0000-0003-1399-5222.[2] On the basis of the supplied bibliometric information and stated research area, the researcher is presented in connection with the Innovative Molecular Biologist Award under the International Molecular Biologist Awards.

Keywords

Keywords: Seyed Hossein Shahcheraghi; Molecular Pharmacology; Molecular Biology; Pharmacology; Biomedical Research; Research Impact; Bibliometrics; Scopus; ORCID; Innovative Molecular Biologist Award.

Introduction

Molecular pharmacology examines pharmacological phenomena at the molecular and cellular levels, linking biological mechanisms with the actions of drugs and other bioactive compounds. Modern pharmacological research increasingly incorporates molecular targets, signaling pathways, cellular responses, and mechanisms that influence therapeutic activity. The identification and characterization of molecular targets are consequently important components of contemporary drug discovery and pharmacological investigation.[4]

Within this broader scientific context, the research profile of Seyed Hossein Shahcheraghi is identified with molecular pharmacology and is associated with Yazd Shahid Sadoughi University of Medical Sciences Campus in Iran. The bibliographic indicators supplied for the profile provide a measurable description of publication activity and citation influence within indexed scholarly literature.[1]

Research Profile

The researcher’s stated subject area is Molecular Pharmacology. The supplied Scopus information identifies the researcher with Author ID 55935316300 and records 75 documents, 820 citations, and an h-index of 13.[1] These values are bibliometric descriptors of the indexed research record and may change as additional publications and citations are incorporated into bibliographic databases.

  • Researcher: Seyed Hossein Shahcheraghi
  • Institution: Yazd Shahid Sadoughi University of Medical Sciences Campus
  • Country: Iran
  • Primary subject area: Molecular Pharmacology
  • Scopus documents: 75
  • Scopus citations: 820
  • h-index: 13
  • ORCID: 0000-0003-1399-5222

The ORCID identifier provides a persistent researcher identifier intended to support reliable attribution of scholarly works and distinguish researchers across systems.[2] Used alongside bibliographic identifiers such as Scopus Author ID, persistent identifiers can assist in organizing and validating scholarly records.

Research Contributions

The available information places Shahcheraghi’s research within molecular pharmacology. At this level of description, the most appropriate characterization is a field-based one rather than a claim concerning a particular molecular pathway, therapeutic target, disease model, or individual discovery, because those details are not specified in the supplied researcher profile.

Molecular pharmacology encompasses the study of interactions between pharmacologically active molecules and biological systems. Research in this area may connect molecular targets with cellular mechanisms and pharmacological outcomes, contributing to the broader understanding of drug action and therapeutic development.[4] The researcher’s stated subject-area classification therefore provides the principal basis for describing the scientific domain represented in this recognition profile.

Publications

The supplied bibliometric record reports 75 documents indexed under the researcher’s Scopus Author ID. This publication count represents the document total provided for the profile at the time of preparation and should be understood as a database-derived indicator rather than a complete independent bibliography of every scholarly work associated with the researcher.[1]

A publication-level assessment would ordinarily examine article titles, journals, publication dates, co-authorship, citation patterns, research topics, and persistent identifiers such as DOI records. No individual publication list or researcher-specific DOI information was supplied for this page; therefore, no specific article is attributed to Shahcheraghi without an independently verified bibliographic record.

Research Impact

The supplied Scopus profile reports 820 citations and an h-index of 13.[1] Citation counts provide one quantitative measure of how frequently indexed scholarly documents have been cited, while the h-index combines publication and citation information into a single bibliometric indicator. Such measures are useful for describing research visibility but do not, by themselves, establish the quality, originality, or practical significance of individual research contributions.

The reported document and citation figures provide a quantitative basis for recognizing an established publication record within indexed literature. They should nevertheless be interpreted in relation to disciplinary practices, publication age, database coverage, authorship patterns, and other qualitative evidence when making a comprehensive assessment of research influence.

Award Suitability

The profile is presented in connection with the Innovative Molecular Biologist Award under the International Molecular Biologist Awards. The stated field of Molecular Pharmacology provides a direct connection to molecular-level biological research, while the reported Scopus record supplies quantitative evidence of sustained scholarly publication and citation activity.[1]

On the information provided, the recognition profile can be framed around three principal elements: an identified academic affiliation, a defined molecular pharmacology subject area, and a documented bibliometric record. The award suitability statement is therefore descriptive of the supplied profile and does not constitute an independent peer-review judgment or a claim of comparative superiority over other researchers.

Conclusion

Seyed Hossein Shahcheraghi is identified with Yazd Shahid Sadoughi University of Medical Sciences Campus, Iran, and with the research area of Molecular Pharmacology. The supplied Scopus profile reports 75 documents, 820 citations, and an h-index of 13, while ORCID provides the persistent identifier 0000-0003-1399-5222.[1] [2]

These identifiers and bibliometric indicators establish the principal factual basis of this academic recognition page. In the context of the International Molecular Biologist Awards, the profile supports presentation under the Innovative Molecular Biologist Award while maintaining a distinction between documented bibliometric information and broader qualitative judgments concerning scientific achievement.

References

  1. Elsevier. (n.d.). Scopus author details: Seyed Hossein Shahcheraghi, Author ID 55935316300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55935316300
  2. ORCID. (n.d.). Seyed Hossein Shahcheraghi — ORCID record. ORCID.
    https://orcid.org/0000-0003-1399-5222
  3. International Molecular Biologist Awards. (n.d.). International Molecular Biologist Awards.
    https://molecularbiologist.org/
  4. Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., & Overington, J. P. (2017). A comprehensive map of molecular drug targets. Nature Reviews Drug Discovery, 16, 19–34.
    https://doi.org/10.1038/nrd.2016.230
  5. Molecular pharmacology and drug-target research. DOI-linked scholarly literature concerning molecular drug targets and pharmacological mechanisms.
    https://doi.org/10.1038/nrd.2016.116

Alexei Tumanov | Immunology | Innovative Research Award

Published on by Molecular Biologist

Innovative Research Award

Alexei Tumanov
The University of Texas at San Antonio, United States

Alexei Tumanov
Affiliation The University of Texas at San Antonio
Country United States
Google Scholar ID EDMA9agAAAAJ
Documents 97
Citations 7,514
h-index 41
Subject Area Immunology
Event International Molecular Biologist Awards
ORCID 0000-0001-6042-0152
Scopus 35351917100

Alexei Tumanov is an immunology researcher affiliated with the University of Texas at San Antonio and the Department of Microbiology, Immunology and Molecular Genetics at UT Health San Antonio. Institutional and bibliographic sources describe his research in relation to cytokine signaling, lymphotoxin biology, immune regulation, lymphoid-organ biology, inflammation, cancer immunotherapy and neuroimmune mechanisms.[1][2]

Abstract

Alexei Tumanov’s research profile is centered on molecular and cellular immunology, with particular emphasis on lymphotoxin signaling and its relationship to immune-system organization, inflammatory responses and disease mechanisms. His institutional research record includes investigations of lymphotoxin-beta receptor signaling, innate and adaptive immune responses, cancer immunotherapy and neuroimmune interactions.[1] Recent publications have examined lymphotoxin-beta receptor regulation of chronic pain, ferroptosis-associated regulation of innate lymphoid cell responses, and strategies intended to separate antitumor activity from immune-mediated toxicity in CD137-directed cancer immunotherapy.[2][3]

Keywords

  • Immunology
  • Molecular Immunology
  • Lymphotoxin Signaling
  • Lymphotoxin-beta Receptor
  • Cytokine Biology
  • Innate Immunity
  • Cancer Immunotherapy
  • Neuroimmune Regulation
  • Inflammation

Introduction

Molecular immunology examines how signaling pathways, immune-cell interactions and tissue environments regulate protective immunity and inflammatory disease. Within this field, lymphotoxin signaling represents an important area for studying the organization and maintenance of lymphoid tissues and the communication between immune and non-immune cells. Tumanov’s research has addressed these mechanisms through experimental studies of lymphotoxin pathways and their roles in immune-system development and disease-related processes.[1]

His earlier work included conditional targeting studies of lymphotoxin pathways in lymphoid organs. Such research contributed to the characterization of cell-specific functions of lymphotoxin and lymphotoxin-beta receptor signaling in peripheral lymphoid-organ development and maintenance.[4] More recent work has extended this research framework to inflammatory bowel disease, cancer immunotherapy and neuroimmune signaling.[2][3]

Research Profile

Institutional information identifies Tumanov as a researcher in the Department of Microbiology, Immunology and Molecular Genetics at UT Health San Antonio. His documented research interests include immune regulation, cytokine signaling and lymphotoxin biology. His research profile also encompasses interactions between immune pathways and pathological processes, including inflammation, cancer and chronic pain.[1][2]

The research program has included both fundamental and disease-oriented investigations. Earlier studies examined lymphotoxin-dependent organization of lymphoid organs, while later studies have investigated how related signaling mechanisms can influence therapeutic toxicity, inflammatory responses and sensory-neural processes.[4][5]

Research Contributions

A central contribution of Tumanov’s research is the investigation of lymphotoxin-beta receptor signaling as a regulator of immune and tissue processes. Experimental work has examined how this receptor pathway contributes to lymphoid-organ development and maintenance and how alterations in the pathway can affect inflammatory and pathological responses.[4]

In cancer immunotherapy, Tumanov has investigated mechanisms associated with the toxicity of CD137-directed treatment. A Cancer Prevention and Research Institute of Texas grant lists him as principal investigator for a project examining the role of lymphotoxin-beta receptor signaling in overcoming liver toxicity associated with anti-CD137 cancer immunotherapy.[5]

His recent collaborative research has also examined neuroimmune mechanisms. A 2026 Cell Reports publication reported that lymphotoxin-beta receptor signaling is involved in the development of chronic pain, providing experimental evidence connecting an immune signaling pathway with sensory processes.[3]

Additional work published in Cellular & Molecular Immunology examined ferroptosis in relation to ILC2 responses in inflammatory bowel disease. The article identifies lymphotoxin-related immunological research within a broader investigation of inflammatory mechanisms affecting innate lymphoid cells.[2]

Publications

Tumanov’s publication record spans molecular immunology, cytokine signaling, lymphoid-organ biology, inflammatory disease, cancer immunotherapy and neuroimmune regulation. His institutional profile lists publications including recent studies in Science Advances, Cell Reports and Cellular & Molecular Immunology.[1]

  • Tumanov, A. V., et al. (2026). Lymphotoxin-beta receptor controls the development of chronic pain. Cell Reports, 45(4), 117269. DOI: 10.1016/j.celrep.2026.117269.[3]
  • Korchagina, A. A., & Tumanov, A. V. (2026). Ferroptosis shapes ILC2 responses in inflammatory bowel disease. Cellular & Molecular Immunology, 23, 583–585. DOI: 10.1038/s41423-026-01404-z.[2]
  • Shein, S. A., Korchagina, A. A., Wang, L.-J., et al., including Tumanov, A. V. (2026). Selective elimination of circulating effector CD8 T cells via LTβR blockade separates anti-CD137 efficacy from toxicity. Science Advances, 12(17), eaea8737.[1]
  • Tumanov, A. V., et al. (2003). Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunological Reviews. DOI: 10.1034/j.1600-065X.2003.00071.x.[4]

Research Impact

The documented research program connects fundamental immunological mechanisms with disease-oriented questions. Institutional records describe grant-supported research into the regulation of cancer immunotherapy toxicity and the role of lymphotoxin-beta receptor signaling in sensory neurons, while recent publications extend the research into chronic pain and inflammatory bowel disease.[2][3][5]

The quantitative metrics supplied for this recognition profile list 97 documents, 7,514 citations and an h-index of 41. Such metrics are bibliographic indicators and should be interpreted according to the database, date of retrieval and author-profile methodology used. The supplied Google Scholar, ORCID and Scopus identifiers provide external routes for verification and updating of these records.

The translational relevance of the research is also reflected in grant-supported projects. CPRIT records identify Tumanov as principal investigator of research concerning anti-CD137 cancer immunotherapy and lymphotoxin-beta receptor signaling, illustrating an application-oriented dimension of his immunological research.[5]

Award Suitability

The documented research themes are closely associated with molecular and cellular immunology, including cytokine signaling, lymphotoxin biology, immune-cell regulation and disease mechanisms. His publication record and institutionally documented research projects provide identifiable evidence of sustained activity in these areas.[1][5]

For the purposes of the International Molecular Biologist Awards, the supplied recognition category is the Innovative Research Award. This article records the relationship between the stated award category and the documented research profile without assigning an independent assessment of scientific merit.

Conclusion

Alexei Tumanov’s research profile encompasses molecular immunology, lymphotoxin signaling and the regulation of immune responses in physiological and pathological settings. His documented work includes studies of lymphoid-organ biology, inflammatory disease, cancer immunotherapy and neuroimmune mechanisms. Recent publications demonstrate continuing investigation of lymphotoxin-beta receptor pathways and immune-cell regulation, while grant records document support for translational research involving cancer immunotherapy.[1][2][3][5]

References

  1. UT Health San Antonio. (n.d.). Tumanov, Alexei, M.D., Ph.D. — Microbiology, Immunology & Molecular Genetics. Institutional researcher profile.
    https://lsom.uthscsa.edu/mimg/team-member/alexei-v-tumanov-m-d-ph-d/
  2. Korchagina, A. A., & Tumanov, A. V. (2026). Ferroptosis shapes ILC2 responses in inflammatory bowel disease. Cellular & Molecular Immunology, 23, 583–585. DOI: 10.1038/s41423-026-01404-z.
    https://doi.org/10.1038/s41423-026-01404-z
  3. Tumanov, A. V., Mecklenburg, J. M., Belugin, S., et al. (2026). Lymphotoxin-beta receptor controls the development of chronic pain. Cell Reports, 45(4), 117269. DOI: 10.1016/j.celrep.2026.117269.
    https://doi.org/10.1016/j.celrep.2026.117269
  4. Tumanov, A. V., et al. (2003). Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunological Reviews. DOI: 10.1034/j.1600-065X.2003.00071.x.
    https://doi.org/10.1034/j.1600-065X.2003.00071.x
  5. Cancer Prevention and Research Institute of Texas. (2022). Grant RP220470: Overcoming liver toxicity of anti-CD137 cancer immunotherapy. Principal Investigator: Alexei Tumanov. University of Texas Health Science Center at San Antonio.
    https://www.cprit.texas.gov/grants-funded/grants/rp220470

Mehmet Kizilkaya | Cancer Biology | Innovative Research Award

Published on by Molecular Biologist

Innovative Research Award

Mehmet Kizilkaya
Researcher Mehmet Kizilkaya
Affiliation Trabzon Kanuni Training and Research Hospital
Country Turkey
Google Scholar ID LoT5L1kAAAAJ
Documents 1
Citations 1
h-index 0
Subject Area Cancer Biology
Event International Molecular Biologist Awards
ORCID 0000-0003-0266-3919

Mehmet Kizilkaya

Trabzon Kanuni Training and Research Hospital, Turkey

Mehmet Kizilkaya and places his documented publication activity within the broader field of cancer-related research. The Innovative Research Award recognizes research activity involving novel approaches, scientific problem solving, and contributions to the development or application of knowledge.[1][2]

Abstract

Mehmet Kizilkaya is presented in this recognition profile as a researcher working in the cancer biology and oncology-related research domain. The supplied academic record lists one document, one citation, and an h-index of zero. A publicly indexed publication bearing his name addresses the screening of oncology patients for COVID-19 before radiotherapy, while another indexed article lists him as a co-author on research examining dosimetric effects during radiotherapy for gynecologic cancer.[1][2]

Keywords

Cancer Biology, Oncology, Radiation Oncology, Radiotherapy, Gynecologic Cancer, Cancer Research, Clinical Research, Medical Research, Dosimetry, Innovative Research.

Introduction

Cancer research encompasses biological, clinical, diagnostic, therapeutic, and technological investigations directed toward improving the understanding and management of malignant disease. Radiation oncology represents an interdisciplinary component of cancer care in which treatment planning, imaging, dosimetry, and patient-specific clinical considerations are integrated into radiotherapy practice. The documented publications associated with Mehmet Kizilkaya include research concerning oncology patients undergoing radiotherapy and treatment-planning considerations in gynecologic cancer.[1][2]

Research Profile

The supplied profile identifies Mehmet Kizilkaya with Trabzon Kanuni Training and Research Hospital in Turkey and places the research subject area within Cancer Biology. His publicly indexed scholarly record includes oncology-related research performed in the context of radiation oncology. An institutional academic record associated with the same name lists publications involving radiotherapy, oncology patients, and treatment dosimetry.[1][2]

  • Research area supplied for this recognition profile: Cancer Biology.
  • Research themes documented in indexed publications include oncology and radiation oncology.
  • Scholarly work includes clinical and treatment-related research involving cancer patients.
  • Google Scholar profile identifier: LoT5L1kAAAAJ.

Research Contributions

One documented contribution is the 2022 publication Results of Screening Oncology Patients for COVID-19 Before Radiotherapy: Single Center Experience. The article reports a single-center screening experience involving oncology patients before radiotherapy and considers the prevention of infectious transmission in the cancer-treatment setting.[1]

A further publication, appearing in the Turkish Journal of Oncology in 2025, lists Mehmet Kizilkaya among its authors and examines the dosimetric effects of bladder and rectum filling in patients with gynecologic cancer receiving adjuvant radiotherapy. The study was published with DOI 10.5505/tjo.2024.4429.[2]

Publications

  • Results of Screening Oncology Patients for COVID-19 Before Radiotherapy: Single Center Experience. UHOD / International Journal of Hematology and Oncology, 2022, 32(3), 188–190. DOI: 10.4999/uhod.226389.[1]
  • Evaluation of the Dosimetric Effects of Bladder and Rectum Filling in Patients with Gynecologic Cancer Receiving Adjuvant Radiotherapy. Turkish Journal of Oncology, 2025, 40(1), 11–19. DOI: 10.5505/tjo.2024.4429.[2]

The publication record should be interpreted together with the researcher’s complete scholarly profile because individual database records may differ in coverage, indexing dates, author disambiguation, and citation updating. The supplied Google Scholar profile is therefore included as an external source for continued verification of publication activity.[3]

Research Impact

The supplied bibliometric information records one document, one citation, and an h-index of zero. These values represent the information provided for this award profile and should not be interpreted as a complete assessment of scientific influence. Citation-based indicators are dependent on database coverage, publication age, field-specific citation practices, and the timing of database updates.[3]

The documented oncology publications nevertheless provide evidence of participation in clinical research addressing radiotherapy practice and cancer-patient management. The 2025 dosimetric study, for example, investigated the relationship between bladder and rectum filling and radiation-treatment planning parameters in gynecologic cancer patients.[2]

Award Suitability

The Innovative Research Award profile is based on documented research participation, subject relevance, publication activity, and the supplied academic identifiers. Mehmet Kizilkaya’s indexed work concerns clinically relevant oncology and radiotherapy questions, including cancer-patient screening and treatment dosimetry.[1][2] Final award decisions, however, remain matters for the designated award evaluation and review process.

Conclusion

Mehmet Kizilkaya’s documented research activity includes contributions to oncology and radiation-oncology research. His identified publications address practical clinical questions involving radiotherapy and cancer patients, while the supplied academic profile provides corresponding scholarly identifiers and bibliometric information. These records form the documentary basis for this academic recognition page.[1][2][3]

References

  1. Kizilkaya, M., Genc, M., Aksu, M. G., Koca, T., & Korcum, A. F. (2022). Results of Screening Oncology Patients for COVID-19 Before Radiotherapy: Single Center Experience. International Journal of Hematology and Oncology, 32(3), 188–190.
    https://doi.org/10.4999/uhod.226389
  2. Koca, T., Aksoy, R. A., Atak, E., Kizilkaya, M., Bilek, Y., Tunçel, N., Sarpün, İ. H., & Korcum, A. F. (2025). Evaluation of the Dosimetric Effects of Bladder and Rectum Filling in Patients with Gynecologic Cancer Receiving Adjuvant Radiotherapy. Turkish Journal of Oncology, 40(1), 11–19.
    https://doi.org/10.5505/tjo.2024.4429
  3. Google Scholar. (n.d.). Mehmet Kizilkaya — Google Scholar profile. Google Scholar.
    https://scholar.google.com/citations?user=LoT5L1kAAAAJ&hl=tr
  4. ORCID. (n.d.). Mehmet Kizilkaya — ORCID record. ORCID.
    https://orcid.org/0000-0003-0266-3919
  5. International Molecular Biologist Awards. (n.d.). Official Award Website.
    https://molecularbiologist.org/

Filiz AKIN | Fertigation | Innovative Research Award

Published on by Molecular Biologist

Innovative Research Award

Filiz AKIN
Researcher Filiz AKIN
Affiliation West Mediterranean Agricultural Research Institute
Country Turkey
Google Scholar ID TGzn7U8AAAAJ
Documents 2
Citations 25
h-index 3
Subject Area Fertigation
Event International Molecular Biologist Awards
ORCID 0000-0002-0902-475X
Scopus 59979471900

Filiz AKIN

West Mediterranean Agricultural Research Institute, Turkey

Filiz AKIN, a researcher affiliated with the West Mediterranean Agricultural Research Institute in Turkey. Her listed subject area is fertigation, an agricultural management approach involving the application of nutrients through irrigation systems. The Innovative Research Award recognizes research activities that introduce new approaches, improve established methodologies, or contribute to the development of practical solutions within a scientific discipline. [1][2]

Abstract

Filiz AKIN is affiliated with the West Mediterranean Agricultural Research Institute in Turkey and is associated with the subject area of fertigation. The supplied scholarly profile records two documents, 25 citations, and an h-index of 3. These indicators provide a limited quantitative overview of the researcher’s indexed scholarly activity. A fuller assessment of research significance requires examination of individual publications, methodologies, findings, and contributions to agricultural science.[1][2]

Keywords

Filiz AKIN, Innovative Research Award, Fertigation, Agricultural Research, Irrigation Management, Nutrient Application, Sustainable Agriculture, Agricultural Engineering, Scholarly Publications, Research Impact.

Introduction

Fertigation refers to the application of dissolved plant nutrients through irrigation systems. The approach can support the coordinated management of water and nutrient delivery, although its effectiveness depends on crop requirements, irrigation uniformity, soil characteristics, nutrient compatibility, and appropriate management practices.[3]

Research in this area contributes to the broader study of agricultural productivity, resource-use efficiency, and sustainable crop production. The evaluation of innovative agricultural research generally considers the scientific rationale, experimental design, reproducibility, practical relevance, and the extent to which findings advance existing knowledge.[3][4]

Research Profile

The available profile identifies Filiz AKIN as a researcher affiliated with the West Mediterranean Agricultural Research Institute. Her listed research subject is fertigation, which is situated at the intersection of irrigation science, plant nutrition, soil management, and agricultural engineering.

  • Researcher: Filiz AKIN.
  • Institution: West Mediterranean Agricultural Research Institute.
  • Country: Turkey.
  • Subject area: Fertigation.
  • Reported scholarly documents: 2.
  • Reported citations: 25.
  • Reported h-index: 3.

The supplied researcher identifiers include a Google Scholar profile, an ORCID record, and a Scopus author profile. These identifiers can assist with distinguishing scholarly records and locating additional information about publications and research activities.[1][2]

Research Contributions

Fertigation research may address the optimization of nutrient delivery, irrigation scheduling, fertilizer-use efficiency, crop response, and the management of agricultural inputs. Such investigations can support evidence-based decisions concerning irrigation and plant nutrition when supported by appropriate experimental data.[3]

The available information associates Filiz AKIN with fertigation research; however, it does not provide sufficient publication-level evidence to identify specific experiments, crop systems, technologies, or original findings. Accordingly, detailed claims concerning individual scientific contributions should be based on verified articles and institutional research records.

Publications

The supplied scholarly profile reports two documents associated with the researcher. The available information does not include the titles, publication dates, journals, co-authors, abstracts, or digital object identifiers of those documents.

  • Reported number of documents: 2.
  • Reported citation count: 25.
  • Reported h-index: 3.

For accurate bibliographic evaluation, publication details should be checked against the researcher’s indexed records and the original publisher pages. No specific publication DOI has been supplied for inclusion in this profile.

Research Impact

The reported citation count and h-index offer quantitative indicators of scholarly visibility. The h-index is a bibliometric measure that combines publication output and citation frequency, but it should not be interpreted as a complete measure of research quality or societal benefit.[4]

In agricultural research, impact may also be assessed through the practical adoption of technologies, improvements in resource-use efficiency, contributions to sustainable production, collaboration with agricultural institutions, and the reproducibility of scientific findings. These dimensions require evidence beyond the numerical indicators provided in the current profile.[3]

Award Suitability

The Innovative Research Award is relevant to research that demonstrates originality, methodological development, scientific value, or practical innovation. Filiz AKIN’s stated association with fertigation provides a subject-area basis for consideration within agricultural and applied research categories.

The reported scholarly indicators may be considered as part of an academic evaluation, but they do not independently establish the originality or significance of particular research findings. A comprehensive award assessment should include verified publications, research contributions, peer-reviewed evidence, institutional affiliation, and the criteria established by the International Molecular Biologist Awards.[4][5]

Conclusion

Filiz AKIN is identified as a researcher affiliated with the West Mediterranean Agricultural Research Institute in Turkey, with a listed subject area of fertigation. The supplied profile reports two documents, 25 citations, and an h-index of 3. These details provide a concise overview of the researcher’s reported scholarly activity. Further evaluation of innovative research contributions would require examination of the underlying publications and their scientific or practical significance.

References

  1. Elsevier. (n.d.). Scopus author details: Filiz AKIN, Author ID 59979471900. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59979471900
  2. Google Scholar. (n.d.). Scholar profile of Filiz AKIN. Google Scholar.
    https://scholar.google.co.uk/citations?user=TGzn7U8AAAAJ&hl=en&oi=ao
  3. Food and Agriculture Organization of the United Nations. (n.d.). Fertigation and irrigation management in agricultural production. FAO.
    https://www.fao.org/land-water/water/water-efficiency/en/
  4. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  5. International Molecular Biologist Awards. (n.d.). Official Award Website.
    https://molecularbiologist.org/

Karim Echtay | Biochemistry | Innovative Research Award

Published on by Molecular Biologist

Innovative Research Award

Karim Echtay
Researcher Karim Echtay
Affiliation University of Balamand
Country Lebanon
Scopus ID 6602196767
Documents 36
Citations 4,853
h-index 25
Subject Area Biochemistry
Event International Molecular Biologist Awards
ORCID 0000-0002-2134-5804
Google Scholar 6oTANJMAAAAJ

Karim Echtay

University of Balamand, Lebanon

Karim Echtay is a researcher affiliated with the University of Balamand in Lebanon whose academic profile is associated with the field of biochemistry. His scholarly record includes 36 documents, 4,853 citations, and an h-index of 25, according to the supplied research-profile information. These indicators provide a quantitative overview of his publication activity and citation visibility within the scientific literature.[1]

Abstract

This article presents an academic recognition profile of Karim Echtay, a researcher affiliated with the University of Balamand, Lebanon. His stated subject area is biochemistry, and his supplied bibliometric record includes 36 documents, 4,853 citations, and an h-index of 25. The profile discusses the relevance of scholarly productivity, citation-based indicators, and research innovation to academic recognition. While bibliometric measures can help describe research visibility, they do not independently establish the originality, quality, or practical significance of individual studies.[1][2]

Keywords

Karim Echtay, Innovative Research Award, Biochemistry, University of Balamand, Lebanon, Scientific Research, Scholarly Publications, Citation Impact, Research Evaluation, Academic Recognition, Research Innovation.

Introduction

Biochemistry examines the chemical processes and molecular mechanisms underlying biological systems. Research in this field contributes to understanding biological functions, molecular interactions, metabolic pathways, disease mechanisms, and the development of scientific and biomedical applications. Academic contributions may be assessed through peer-reviewed publications, methodological advances, reproducibility, collaboration, and the relevance of research findings to a particular scientific problem.

The evaluation of research performance frequently incorporates bibliometric indicators. Citation counts provide information about the number of recorded citations associated with a researcher’s publications, whereas the h-index combines publication and citation information into a single indicator. Such measures should be interpreted in relation to disciplinary practices, career stage, publication types, and the time period covered by the relevant database.[2][3]

Research Profile

Karim Echtay is identified in the supplied information as a researcher at the University of Balamand in Lebanon. His stated academic subject area is biochemistry. The following details summarize the research-profile information provided for this article.

  • Researcher: Karim Echtay.
  • Institution: University of Balamand.
  • Country: Lebanon.
  • Subject area: Biochemistry.
  • Scopus Author ID: 6602196767.
  • Reported documents: 36.
  • Reported citations: 4,853.
  • Reported h-index: 25.

The reported Scopus identifier provides a means of locating the corresponding author record in the Scopus database. Author-profile information can be used to examine indexed publications, citation records, and related bibliometric information, subject to database coverage and profile accuracy.[1]

Research Contributions

The supplied information identifies biochemistry as Karim Echtay’s principal subject area. Biochemical research may involve the investigation of molecular structures, enzyme activity, cellular processes, protein function, metabolic regulation, and the chemical basis of biological phenomena. However, the specific research themes, experimental methods, and individual scientific contributions associated with the researcher cannot be established solely from the supplied bibliometric indicators.

A complete assessment of research contributions would require examination of the researcher’s publications, including their objectives, methods, findings, limitations, and relationship to previous literature. Particular attention may be given to the originality of research questions, methodological rigor, reproducibility, and the extent to which findings advance understanding within biochemistry.

Publications

The supplied profile reports 36 scholarly documents associated with Karim Echtay. These records may include different publication types, depending on the classification used by the relevant indexing database. A detailed publication analysis would require verification of individual titles, authorship, journal information, publication dates, document types, and subject classifications.

  • Reported publication documents: 36.
  • Reported research subject: Biochemistry.
  • Publication records may be examined through the supplied Scopus author profile.
  • Individual publication titles and DOI identifiers require verification before being included as confirmed research outputs.

No specific publication titles or verified DOI records were supplied for this article. Accordingly, no individual paper is attributed to the researcher here without additional bibliographic confirmation.

Research Impact

The supplied bibliometric information reports 4,853 citations and an h-index of 25 for Karim Echtay. Citation counts can indicate the extent to which published research has been referenced in subsequent scholarly work. The h-index is intended to summarize a combination of publication productivity and citation impact, although its interpretation varies among disciplines and research communities.[2][3]

Bibliometric indicators should be considered alongside qualitative evidence, including the significance of research findings, contributions to scientific methods, collaboration, mentorship, research integrity, and practical or theoretical applications. Citation-based measures alone do not establish the quality or originality of a researcher’s work.[3]

Award Suitability

The Innovative Research Award is intended to recognize research associated with originality, scientific advancement, and meaningful contributions to a defined field. Karim Echtay’s supplied academic profile includes an affiliation with the University of Balamand, a stated specialization in biochemistry, and reported bibliometric indicators of 36 documents, 4,853 citations, and an h-index of 25.

These details may provide contextual information for an academic recognition process. A substantive award assessment should additionally consider verified publications, research originality, methodological quality, the significance of findings, independent scholarly evaluation, and the specific eligibility criteria established by the awarding organization. The information presented in this article does not constitute an independent adjudication of award eligibility or selection.

Conclusion

Karim Echtay is identified as a biochemistry researcher affiliated with the University of Balamand in Lebanon. The supplied research profile reports 36 documents, 4,853 citations, and an h-index of 25. These indicators provide a quantitative description of scholarly activity and citation visibility. Further evaluation of research innovation and scientific contribution would require examination of verified publications and qualitative evidence. The profile is presented in connection with the Innovative Research Award of the International Molecular Biologist Awards.

References

  1. Elsevier. (n.d.). Scopus author details: Karim Echtay, Author ID 6602196767. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6602196767
  2. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  3. Hicks, D., Wouters, P., Waltman, L., de Rijcke, S., & Rafols, I. (2015). Bibliometrics: The Leiden Manifesto for research metrics. Nature, 520, 429–431.
    https://doi.org/10.1038/520429a
  4. ORCID. (n.d.). ORCID record: Karim Echtay. ORCID.
    https://orcid.org/0000-0002-2134-5804
  5. International Molecular Biologist Awards. (n.d.). Official Award Website.
    https://molecularbiologist.org/

Tamara Sakhno | Enzymology | Research Excellence Award

Published on by Molecular Biologist

Research Excellence Award

              Tamara Sakhno
Researcher Tamara Sakhno
Affiliation Poltava University of Economics and Trade
Country Ukraine
Scopus ID 7003968703
Documents 54
Citations 286
h-index 9
Subject Area Enzymology
Event International Molecular Biologist Awards
ORCID 0000-0001-7049-4657
Google Scholar 0JNwwgYAAAAJ

Tamara Sakhno

Poltava University of Economics and Trade, Ukraine

Tamara Sakhno, whose stated subject area is Enzymology. The Research Excellence Award recognizes researchers whose scholarly activity demonstrates sustained contribution to scientific knowledge, publication activity, research visibility, and measurable academic impact. This academic recognition profile presents the publicly identified research information associated with publication output and bibliometric indicators as complementary measures of scholarly activity rather than as a substitute for qualitative peer evaluation.[1]

Abstract

Tamara Sakhno is a researcher affiliated with Poltava University of Economics and Trade in Ukraine. Her academic profile is identified with the field of Enzymology and is represented in the Scopus database by Author ID 7003968703. The supplied bibliometric record lists 54 documents, 286 citations, and an h-index of 9. These indicators provide a quantitative overview of research visibility and publication activity and should be interpreted alongside the content, originality, and significance of individual scholarly contributions.[1]

Keywords

Tamara Sakhno, Research Excellence Award, Enzymology, enzyme research, biochemical sciences, scientific publications, research impact, bibliometrics, Scopus, ORCID, scholarly communication, Ukraine.

Introduction

Enzymology is a branch of biochemical science concerned with enzymes, their catalytic functions, mechanisms, regulation, and applications. Research in this area contributes to the broader understanding of biological processes and can intersect with biotechnology, food science, medicine, environmental science, and industrial applications. Scholarly assessment in such fields commonly considers both qualitative research contributions and quantitative indicators of publication and citation activity.[2]

Bibliometric measures can help describe the reach of published research. The h-index, for example, was proposed as an indicator combining publication productivity with citation impact, although it has recognized limitations and should not be used as the sole measure of research quality.[3]

Research Profile

The available researcher information places Tamara Sakhno within the academic environment of Poltava University of Economics and Trade and identifies Enzymology as the principal subject area. Her researcher identifiers provide mechanisms for distinguishing her scholarly record across major academic information systems.

  • Institutional affiliation: Poltava University of Economics and Trade.
  • Country of affiliation: Ukraine.
  • Primary subject area supplied for this profile: Enzymology.
  • Scopus Author ID: 7003968703.
  • ORCID identifier: 0000-0001-7049-4657.
  • Google Scholar profile identifier: 0JNwwgYAAAAJ.

Persistent researcher identifiers such as ORCID are designed to help distinguish researchers and connect their scholarly activities across systems, while bibliographic databases such as Scopus provide structured information concerning indexed publications and citations.[1][4]

Research Contributions

Within the stated field of Enzymology, research contributions may involve investigation of enzyme activity, catalytic mechanisms, biochemical interactions, optimization of enzymatic processes, and applications of enzymes in scientific or industrial contexts. The available bibliometric record establishes a documented publication presence but does not, by itself, provide sufficient evidence to assign specific individual discoveries or claims beyond the indexed profile.

A balanced assessment of research contribution should therefore consider the subject relevance, methodological rigor, originality, reproducibility, collaboration, and practical or theoretical significance of individual publications. Citation indicators can provide supporting evidence of scholarly attention but do not independently establish the scientific quality of a research contribution.[3]

Publications

The supplied Scopus record reports 54 documents associated with Tamara Sakhno. This publication count indicates an established indexed research output. The precise titles, publication venues, authorship positions, subject classifications, and individual citation distributions should be evaluated directly through the relevant bibliographic records when a publication-level assessment is required.[1]

  • Reported Scopus-indexed documents: 54.
  • Reported citations: 286.
  • Reported h-index: 9.
  • Research area associated with the profile: Enzymology.

Research Impact

The reported total of 286 citations provides evidence that the researcher’s indexed publications have received scholarly attention. An h-index of 9 further indicates that at least nine publications in the corresponding dataset have each received at least nine citations, subject to the database’s current indexing and counting methodology.[1][3]

Citation-based indicators can vary between databases because coverage, document types, author matching, citation sources, and update schedules differ. Consequently, the reported figures should be regarded as database-specific measurements rather than fixed measures of overall scientific influence.[3]

Award Suitability

The available profile provides several factors relevant to consideration for a Research Excellence Award, including a documented publication record, measurable citation activity, an established Scopus author profile, and a defined research association with Enzymology. The reported 54 documents and 286 citations indicate sustained scholarly activity within the indexed record.[1]

For a comprehensive award evaluation, these quantitative indicators should be considered together with the originality and significance of the research, quality of publications, contribution to collaborative projects, methodological standards, and broader academic or societal relevance. Such a combined approach provides a more balanced assessment than reliance on bibliometric measures alone.[3]

Conclusion

Tamara Sakhno’s available academic profile documents research activity associated with Poltava University of Economics and Trade and the subject area of Enzymology. The reported record of 54 documents, 286 citations, and an h-index of 9 provides measurable evidence of indexed scholarly activity. These indicators, together with qualitative examination of research outputs, can form part of an evidence-based assessment for academic recognition through the International Molecular Biologist Awards.[1][5]

References

  1. Elsevier. (n.d.). Scopus author details: Tamara Sakhno, Author ID 7003968703. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7003968703
  2. National Center for Biotechnology Information. (n.d.). Enzymology and enzyme-related biomedical research resources. National Library of Medicine.
    https://www.ncbi.nlm.nih.gov/
  3. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  4. ORCID. (n.d.). ORCID record: Tamara Sakhno, ORCID iD 0000-0001-7049-4657.
    https://orcid.org/0000-0001-7049-4657
  5. International Molecular Biologist Awards. (n.d.). Official Award Website.
    https://molecularbiologist.org/

Rose-Mary Boustany | Neurobiology | Research Excellence Award

Published on by Molecular Biologist

Research Excellence Award

          Rose-Mary Boustany
Researcher Rose-Mary Boustany
Affiliation American University of Beirut
Country Lebanon
Scopus ID 7003589401
Documents 112
Citations 4,460
h-index 39
Subject Area Neurobiology
Event International Molecular Biologist Awards
ORCID 0000-0002-2066-0079
Google Scholar zFSl2I0AAAAJ

Rose-Mary Boustany

American University of Beirut, Lebanon

Rose-Mary Boustany is a researcher affiliated with the American University of Beirut whose scholarly profile is associated with the field of neurobiology. The available bibliometric record indicates a substantial body of indexed research, with 112 documents, 4,460 citations, and an h-index of 39. These indicators provide quantitative evidence of sustained scholarly activity and research visibility within the scientific literature.[1]

Abstract

The Research Excellence Award profile for Rose-Mary Boustany presents a summary of her academic affiliation, research discipline, publication record, and bibliometric indicators. Her listed subject area is neurobiology, a field concerned with the biological mechanisms underlying nervous-system structure and function. The reported Scopus record comprises 112 documents, 4,460 citations, and an h-index of 39.[1] Her researcher identity is additionally represented through ORCID and Google Scholar profiles, providing complementary routes for scholarly identification and publication discovery.[2][3]

Keywords

Rose-Mary Boustany, Neurobiology, Neuroscience, Molecular Biology, Biomedical Research, Scientific Publications, Research Impact, Bibliometrics, Citation Analysis, Academic Research.

Introduction

Research recognition commonly considers multiple dimensions of scholarly performance, including publication productivity, citation influence, research quality, originality, collaboration, and contribution to scientific knowledge. Bibliometric indicators such as citation counts and the h-index can provide standardized quantitative measures of scholarly influence, although they are most appropriately interpreted alongside qualitative assessment.[4]

Within this framework, Rose-Mary Boustany’s reported research profile provides measurable indicators of academic productivity and citation visibility. The association with the American University of Beirut places the researcher within an established academic environment for biomedical and life-science research.[1]

Research Profile

The available researcher information identifies Rose-Mary Boustany with the American University of Beirut and the subject area of neurobiology. Her indexed publication record contains 112 documents, while the reported citation count is 4,460 and the h-index is 39.[1]

  • Affiliation: American University of Beirut.
  • Country: Lebanon.
  • Research subject area: Neurobiology.
  • Scopus documents: 112.
  • Reported citations: 4,460.
  • Reported h-index: 39.

Research Contributions

Neurobiology integrates molecular, cellular, physiological, and systems-level approaches to understand the nervous system. Research within this broad field can address neuronal development, cellular signaling, neurodegeneration, synaptic mechanisms, and the molecular basis of neurological function. The research classification associated with Boustany’s profile places her scholarly record within this wider scientific domain.[1]

The reported citation profile indicates that the research record has been referenced substantially within the scholarly literature. Citation measures, however, should not be interpreted independently of publication context, field-specific citation practices, authorship, and the individual significance of particular studies.[4]

Publications

The Scopus record associated with Rose-Mary Boustany lists 112 documents. Scopus provides bibliographic and citation information that can be used to examine publication output and scholarly influence over time.[1] The researcher’s Google Scholar profile provides an additional scholarly discovery source for publications and citation information.[3]

  • 112 documents are reported in the supplied Scopus researcher record.
  • The publication record is associated with neurobiology and related biomedical research.
  • Publication discovery can be supported through Scopus, ORCID, and Google Scholar researcher identifiers.

Research Impact

The reported 4,460 citations and h-index of 39 provide quantitative indicators of the visibility of the researcher’s publications within the indexed scholarly literature.[1] The h-index was originally proposed as a metric intended to combine aspects of publication productivity and citation impact, although its interpretation varies among disciplines and career stages.[4]

Research impact may also be assessed through the quality and relevance of individual publications, contribution to scientific collaboration, methodological advances, reproducibility, and influence on subsequent research. Consequently, bibliometric indicators are best considered as one component of a broader academic evaluation.

Award Suitability

The Research Excellence Award recognizes scholarly achievement based on evidence such as research productivity, scientific visibility, and contribution to a defined academic discipline. Based on the supplied bibliometric information, Rose-Mary Boustany has a substantial indexed publication record and a reported citation profile that may be relevant to an academic recognition process.[1]

Final award decisions should be based on the criteria and independent evaluation procedures established by the organizing body. Bibliometric indicators can support such assessment but do not, by themselves, establish the quality or significance of individual research contributions.

Conclusion

Rose-Mary Boustany’s academic profile is associated with the American University of Beirut and the research area of neurobiology. The supplied Scopus information reports 112 documents, 4,460 citations, and an h-index of 39, providing measurable indicators of publication activity and scholarly visibility.[1] Her ORCID and Google Scholar identifiers provide additional mechanisms for distinguishing and locating her scholarly work.[2][3]

References

  1. Elsevier. (n.d.). Scopus author details: Rose-Mary Boustany, Author ID 7003589401. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7003589401
  2. ORCID. (n.d.). Rose-Mary Boustany — ORCID record.
    https://orcid.org/0000-0002-2066-0079
  3. Google Scholar. (n.d.). Rose-Mary Boustany — Google Scholar profile.
    https://scholar.google.com/citations?user=zFSl2I0AAAAJ&hl=en&oi=sra
  4. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  5. International Molecular Biologist Awards. (n.d.). Official Award Website.
    https://molecularbiologist.org/

Basem Jawa | HIV diagnosis | Innovative Research Award

Published on by Molecular Biologist

Innovative Research Award

                Basem Jawa
Researcher Basem Jawa
Affiliation Makkah Health Cluster
Country Saudi Arabia
Google Scholar bYyqxRAAAAAJ
Citations 1
h-index 1
i10-index 0
Subject Area HIV Diagnosis
Event International Molecular Biologist Awards
ORCID 0009-0004-9964-2472
Scopus ID 60762627800

Basem Jawa

Makkah Health Cluster, Saudi Arabia

The Innovative Research Award recognizes research activity that contributes to scientific knowledge, clinical practice, diagnostic development, or other areas of measurable scholarly value. This academic profile presents the research information available for Basem Jawa, affiliated with the Makkah Health Cluster in Saudi Arabia, with a stated subject area of HIV diagnosis. The profile considers bibliographic visibility, researcher identifiers, and scholarly metrics as components of an academic recognition profile.[1][2]

Abstract

Basem Jawa is a researcher affiliated with the Makkah Health Cluster in Saudi Arabia whose stated research area is HIV diagnosis. Available researcher profiles provide persistent identifiers through Scopus, ORCID, and Google Scholar, enabling scholarly work to be associated with a consistent academic identity. The supplied bibliometric information records one citation and an h-index of 1, with an i10-index of 0. These indicators provide a limited but identifiable snapshot of scholarly visibility and should be interpreted alongside publication quality, research contribution, and broader scientific context.[1][2]

Keywords

HIV Diagnosis, HIV Testing, Molecular Diagnostics, Infectious Disease Diagnostics, Clinical Research, Biomedical Research, Research Innovation, Saudi Arabia, Health Research, Molecular Biology.

Introduction

HIV diagnosis is an important component of infectious disease management because accurate identification of infection supports appropriate clinical care, surveillance, prevention, and public-health interventions. Diagnostic research can involve laboratory methodologies, molecular detection, testing strategies, interpretation of biomarkers, and approaches intended to improve the accuracy or accessibility of testing.

Researcher identification systems such as Scopus Author Profiles, ORCID, and Google Scholar help distinguish individual researchers and provide mechanisms for tracking scholarly publications and citations. Bibliometric measures including citation counts and the h-index are commonly used as supplementary indicators of research visibility, although they do not independently establish the quality or significance of individual research contributions.[3]

Research Profile

The available profile identifies Basem Jawa with the Makkah Health Cluster, Saudi Arabia, and associates the researcher with HIV diagnosis. The supplied scholarly identifiers provide pathways to bibliographic and researcher information across major academic platforms.

  • Affiliation: Makkah Health Cluster, Saudi Arabia.
  • Research subject area: HIV diagnosis.
  • Scopus Author ID: 60762627800.
  • Reported citations: 1.
  • Reported h-index: 1.
  • Reported i10-index: 0.
  • ORCID: 0009-0004-9964-2472.

Research Contributions

Within the stated subject area of HIV diagnosis, relevant scientific contributions may include improvements in diagnostic methodologies, laboratory testing, molecular detection, clinical interpretation, and strategies that support timely identification of infection. The available researcher information establishes the subject-area association but does not provide sufficient evidence to attribute specific diagnostic methods, discoveries, or clinical outcomes to the researcher without reviewing the underlying publications.

Accordingly, the profile distinguishes between the documented researcher identifiers and the broader scientific context of HIV diagnostic research. This approach avoids attributing unsupported findings while recognizing the potential relevance of diagnostic research to biomedical and public-health practice.

Publications

The supplied information identifies a Google Scholar profile and a Scopus Author Profile for Basem Jawa. These platforms can be used to review indexed publications, citation records, co-authorship, and other bibliographic information. Because no individual publication titles or DOI records were supplied, specific articles are not attributed to the researcher in this profile.[1][2]

  • Scopus Author Profile: Basem Jawa, Author ID 60762627800.
  • Google Scholar Profile: Basem Jawa, profile identifier bYyqxRAAAAAJ.
  • ORCID Profile: 0009-0004-9964-2472.

Research Impact

The supplied bibliometric record reports one citation and an h-index of 1, while the i10-index is reported as 0. Such metrics represent measurable scholarly visibility at the time of the supplied profile information but should not be interpreted as a complete assessment of research quality, originality, clinical relevance, or societal impact. Bibliometric indicators can vary between databases and may change as publications receive additional citations.[3]

For a comprehensive assessment of research impact, bibliometric information can be considered together with peer-reviewed publication quality, methodological contribution, collaboration, reproducibility, practical applications, and influence on subsequent research or healthcare practice.

Award Suitability

The Innovative Research Award provides a framework for recognizing researchers whose work demonstrates originality, scientific relevance, and potential contribution to their field. Basem Jawa’s stated specialization in HIV diagnosis places the research profile within an important biomedical and diagnostic context. The available researcher identifiers also provide a basis for independent verification of scholarly records through established academic platforms.[1][2]

Final award assessment should be based on the applicable award criteria and independent evaluation of the candidate’s publications, research methodology, originality, contribution to knowledge, and broader impact. The bibliometric indicators presented in this article should therefore be considered supporting information rather than a sole basis for award selection.

Conclusion

Basem Jawa’s academic profile is associated with the Makkah Health Cluster in Saudi Arabia and the stated subject area of HIV diagnosis. The available profile includes persistent researcher identifiers through Scopus, ORCID, and Google Scholar, together with reported citation and h-index information. These records provide a foundation for documenting scholarly activity and evaluating research development within biomedical and diagnostic research.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Basem Jawa, Author ID 60762627800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=60762627800
  2. Google Scholar. (n.d.). Basem Jawa — Google Scholar Profile.
    https://scholar.google.com/citations?user=bYyqxRAAAAAJ&hl=en&oi=sra
  3. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  4. ORCID. (n.d.). Basem Jawa — ORCID record. ORCID.
    https://orcid.org/0009-0004-9964-2472
  5. International Molecular Biologist Awards. (n.d.). Official Award Website.
    https://molecularbiologist.org/

georges Bahr | Immunology | Innovative Research Award

Published on by Molecular Biologist

 

Innovative Research Award

              Georges Bahr
Researcher Georges Bahr
Affiliation University of Balamand
Country Lebanon
Scopus ID 7102520346
Documents 116
Citations 2,560
h-index 28
Subject Area Immunology
Event International Molecular Biologist Awards

Georges Bahr

University of Balamand, Lebanon

Georges Bahr is affiliated with the University of Balamand in Lebanon and has an indexed research profile in the field of immunology. The Innovative Research Award recognizes researchers whose scholarly work demonstrates sustained scientific activity, originality, and measurable contribution to their respective fields. According to the supplied Scopus profile information, the researcher has 116 documents, 2,560 citations, and an h-index of 28.[1]

Abstract

Georges Bahr’s academic profile reflects an established research record in immunology, supported by a substantial body of indexed scholarly publications and measurable citation activity. The supplied bibliometric data identify 116 documents, 2,560 citations, and an h-index of 28. These indicators provide quantitative evidence of research visibility and scholarly influence, while qualitative assessment of individual publications remains important when evaluating scientific innovation and significance.[1][2]

Keywords

Immunology, Molecular Biology, Cellular Immunology, Immune Response, Biomedical Research, Scientific Publications, Research Impact, Citation Analysis, Translational Research, Academic Excellence.

Introduction

Immunology is a multidisciplinary area of biomedical science concerned with the study of immune-system components, immune responses, host–pathogen interactions, inflammation, and mechanisms underlying immune-mediated disease. Contemporary immunological research frequently integrates molecular biology, cellular biology, genetics, microbiology, and clinical science to investigate mechanisms operating at multiple biological scales.[3]

Academic research profiles in immunology may be assessed using both qualitative and quantitative measures. Bibliometric indicators, including publication counts, citation counts, and the h-index, can provide useful contextual information regarding scholarly dissemination and influence, although they do not independently establish the scientific quality of individual studies.[2][4]

Research Profile

Georges Bahr is associated with the University of Balamand, Lebanon, and is represented in Scopus under author identifier 7102520346. The supplied profile records 116 documents and 2,560 citations, with an h-index of 28. These figures indicate a sustained publication record and citation presence within the indexed scholarly literature.[1]

  • Institutional affiliation: University of Balamand.
  • Country: Lebanon.
  • Primary subject area: Immunology.
  • Scopus author identifier: 7102520346.
  • Indexed documents: 116.
  • Reported citations: 2,560.
  • Reported h-index: 28.

Research Contributions

Research in immunology contributes to understanding the molecular and cellular mechanisms responsible for immune recognition, regulation, inflammation, host defense, and immune-associated disorders. Within this broad discipline, scholarly contributions can encompass experimental investigation, molecular characterization, cellular studies, disease mechanisms, and translational approaches. The available profile information establishes Georges Bahr’s disciplinary classification but does not provide sufficient evidence to assign specific individual discoveries or mechanisms without reviewing the underlying publications.[1][3]

The combination of publication activity and citation accumulation provides an indication that the researcher’s work has been disseminated within the scholarly literature. Detailed evaluation of originality, methodological rigor, reproducibility, and practical significance should be conducted at the publication level by subject-matter experts.[4]

Publications

The supplied Scopus information records 116 documents associated with Georges Bahr. Scopus provides bibliographic and citation information that can be used to examine publication output, citation patterns, collaboration, and subject-area distribution. Individual publication titles, journal details, publication years, and DOI identifiers should be verified directly through the corresponding bibliographic records before being used for detailed publication analysis.[1]

  • Total documents reported in the supplied Scopus profile: 116.
  • Research classification: Immunology.
  • Publication-level DOI information should be verified against individual source records.

Research Impact

The supplied bibliometric profile reports 2,560 citations and an h-index of 28. The h-index was introduced as a measure intended to combine aspects of publication productivity and citation impact, with the value representing a set of publications that have each received at least the corresponding number of citations.[4]

Citation indicators should be interpreted within disciplinary and temporal context because citation practices vary substantially among research fields, publication types, and career stages. Consequently, bibliometric metrics are most appropriately considered alongside peer assessment, research quality, originality, methodological strength, and broader scientific contribution.[2][5]

Award Suitability

The supplied academic indicators provide a quantitative basis for considering Georges Bahr within an award evaluation framework. A record of 116 indexed documents, 2,560 citations, and an h-index of 28 demonstrates sustained scholarly activity and measurable citation impact according to the supplied Scopus data.[1]

For the Innovative Research Award, further evaluation may consider the originality of research questions, significance of findings, methodological innovation, interdisciplinary contribution, reproducibility, mentoring, collaboration, and influence on subsequent research. Final award decisions should remain subject to the applicable eligibility criteria and independent assessment procedures of the International Molecular Biologist Awards.

Conclusion

Georges Bahr, affiliated with the University of Balamand in Lebanon, has a documented scholarly profile in immunology with 116 reported Scopus-indexed documents, 2,560 citations, and an h-index of 28. These indicators demonstrate sustained research activity and measurable scholarly visibility. A comprehensive assessment of research excellence should additionally consider the quality, originality, significance, and reproducibility of the underlying scientific work.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Georges Bahr, Author ID 7102520346. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7102520346
  2. Elsevier. (n.d.). Scopus: Abstract and citation database for peer-reviewed literature. Scopus.
    https://www.scopus.com/
  3. Murphy, K., & Weaver, C. (2016). Janeway’s Immunobiology (9th ed.). Garland Science.
    https://doi.org/10.1201/9781315533247
  4. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  5. International Molecular Biologist Awards. (n.d.). Official Award Website.
    https://molecularbiologist.org/

Adib Mahmoodi Nasrabadi | Biochemistry | Best Researcher Award

Published on by Molecular Biologist

Best Researcher Award

  Adib Mahmoodi Nasrabadi
Researcher Adib Mahmoodi Nasrabadi
Affiliation Florida Atlantic University
Country United States
Scopus ID 57377053100
Documents 13
Citations 302
h-index 7
Subject Area Biochemistry
Event International Molecular Biologist Awards
ORCID 0000-0003-0754-1152
Google Scholar Pa4vmbQAAAAJ

Adib Mahmoodi Nasrabadi

Florida Atlantic University, United States

Adib Mahmoodi Nasrabadi is a researcher affiliated with Florida Atlantic University whose scholarly profile is associated with the field of biochemistry. Available bibliographic records identify 13 documents, 302 citations, and an h-index of 7 in Scopus. These indicators provide quantitative information about publication activity and citation influence within the indexed research literature.[1]

Abstract

Adib Mahmoodi Nasrabadi has developed a scholarly profile in biochemistry supported by indexed publications and measurable citation activity. According to the supplied bibliometric record, the researcher has 13 documents, 302 citations, and an h-index of 7 in Scopus. The profile is further represented through ORCID and Google Scholar, providing persistent and complementary mechanisms for identifying and tracking scholarly work.[1][2][3]

Keywords

Adib Mahmoodi Nasrabadi, Biochemistry, Molecular Biology, Biochemical Research, Scientific Publications, Research Impact, Citation Analysis, Scholarly Communication, Florida Atlantic University.

Introduction

Biochemistry investigates the chemical processes and molecular mechanisms underlying biological systems and forms an important connection between biology, chemistry, medicine, and related life sciences. Researchers working in this field contribute through experimental studies, molecular characterization, biochemical analysis, and interdisciplinary research. Scholarly databases provide structured information that can be used to document publication output and citation activity.[4]

Researcher identifiers also play an important role in distinguishing scholars with similar names and in connecting publications across different information systems. ORCID provides a persistent identifier for researchers, while bibliographic services such as Scopus and Google Scholar provide additional records of scholarly publications and citations.[1][2][3]

Research Profile

The available profile identifies Adib Mahmoodi Nasrabadi with Florida Atlantic University and places the principal subject area within biochemistry. The reported Scopus record contains 13 documents and 302 citations, with an h-index of 7. These values provide a concise bibliometric representation of the researcher’s indexed scholarly output.[1]

  • Affiliation: Florida Atlantic University.
  • Country: United States.
  • Primary subject area: Biochemistry.
  • Scopus documents: 13.
  • Scopus citations: 302.
  • Scopus h-index: 7.

Research Contributions

Research in biochemistry contributes to understanding biological systems at the molecular and chemical levels. Within this broad discipline, scholarly contributions may involve biochemical mechanisms, molecular interactions, biological molecules, cellular processes, analytical methods, and interdisciplinary applications. The documented research profile of Adib Mahmoodi Nasrabadi is situated within this scientific context and is represented through indexed scholarly publications.[1]

Evaluation of research contributions should consider both quantitative indicators and the scientific substance of individual publications. Citation counts and h-index values can provide useful indicators of scholarly visibility, but they do not independently establish the originality, methodological quality, or practical significance of particular studies.[5]

Publications

The supplied Scopus profile records 13 documents associated with the researcher. Publication records can include different forms of scholarly output, and the precise composition of a researcher’s document set should be verified directly through the relevant bibliographic database when detailed publication analysis is required.[1]

  • Documented scholarly output: 13 Scopus-indexed documents.
  • The publication record is associated with the subject area of biochemistry.
  • Publication-level evaluation should consider journal quality, methodology, originality, and research relevance in addition to citation counts.

Research Impact

The reported 302 citations indicate that the researcher’s indexed publications have received measurable attention within the scholarly literature. An h-index of 7 indicates that at least seven indexed publications have each received at least seven citations under the corresponding database’s counting methodology. Bibliometric values can change as databases are updated and should therefore be interpreted as time-dependent indicators.[1][5]

Research impact is multidimensional and may include scholarly influence, methodological contribution, collaboration, knowledge dissemination, and practical or societal applications. Citation-based indicators are most informative when considered alongside qualitative assessment of the underlying research.[5]

Award Suitability

For academic recognition, the documented combination of publication activity, citations, and an h-index provides quantitative evidence that may be considered as part of an award assessment. Adib Mahmoodi Nasrabadi’s profile, together with his affiliation and disciplinary focus in biochemistry, provides a basis for consideration within a research recognition framework such as the International Molecular Biologist Awards.[1]

Final award suitability should be determined through the applicable award criteria and, where appropriate, independent academic review. Bibliometric measures should be treated as supporting evidence rather than as a standalone measure of research quality or scientific merit.[5]

Conclusion

Adib Mahmoodi Nasrabadi is associated with Florida Atlantic University and has a documented research profile in biochemistry. The supplied bibliometric information reports 13 documents, 302 citations, and an h-index of 7 in Scopus. Together with persistent researcher identifiers and scholarly profile records, these data provide a structured overview of his academic visibility and publication activity.[1][2][3]

References

  1. Elsevier. (n.d.). Scopus author details: Adib Mahmoodi Nasrabadi, Author ID 57377053100. Scopus.
    https://www.scopus.com/pages/authors/57377053100
  2. ORCID. (n.d.). Adib Mahmoodi Nasrabadi, ORCID iD 0000-0003-0754-1152. ORCID.
    https://orcid.org/0000-0003-0754-1152
  3. Google Scholar. (n.d.). Adib Mahmoodi Nasrabadi — Google Scholar profile.
    https://scholar.google.com/citations?user=Pa4vmbQAAAAJ&hl=en
  4. Nelson, D. L., & Cox, M. M. (2021). Lehninger Principles of Biochemistry. W. H. Freeman.
    https://doi.org/10.13140/RG.2.2.25222.01603
  5. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102